Rock Creek Pharmaceuticals Announces Clinical Update By: Benzinga via Benzinga June 11, 2015 at 08:01 AM EDT Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic ... Read More >>